Bio, work history, education & how to reach out.
Founder at IgGenix
*******@iggenix.com
+1 **********
Last updated: 2026-03-03
Dr. Jessica Grossman is the CEO of IgGenix, a biotechnology company focused on developing therapies for people with food allergies and other severe allergic conditions. She has over two decades of experience in the medical, pharmaceutical, and biotechnology fields. Dr. Grossman is dedicated to advancing science through leading businesses and non-for-profits.
Prior to joining IgGenix, Dr. Grossman served as CEO of Medicines360. She has also held positions as CEO and President of Sense4Baby, Inc., and Medical Director at Ethicon Endo-Surgery, a Johnson & Johnson company. Dr. Grossman has also founded and led other companies.
Dr. Grossman holds a Bachelor of Arts in Biology and English from Brandeis University and a Doctor of Medicine from Thomas Jefferson University.
IgGenix is a biotechnology company taking a revolutionary approach to directly address allergic disease. The company is developing first-in-class therapies for people limited by food allergies and other severe allergic conditions by re-engineering key antibodies involved in the allergic cascade.
IgGenix has raised $25 million in Series A1 funding and $40M Series B financing.
You can reach Jessica Grossman at *******@iggenix.com or by calling +1 **********. To get Jessica Grossman's contact information and other startup founders like this, sign up for a free account at Anybody.com.
Get thousands of B2B leads like this for free, no credit card required.
Get started for free